Member Info for BuyToHoldForever

Barclays apparently refusing to offer it to customers. Presume the word cannabis off-putting for them, as opposed to an understanding of the medical applications

Interesting interview with CEO...clearly he thinks Kanabo should be valued like the US/Canadian peers, even after a decent opening day on the markets

In the US this is a microcap biotech. $1bn is normal valuation for high risk high reward. Parsortix is derisked and near market. If we were nasdaq listed the value would be > $1bn today. Post FDA clearance and we would be $2-$2bn in short order. I believe we will get there but £200mn today is bargain basement as far as the US market is concerned in the next few years this will be a FTSE250 company if we last that long.

If it was good enough for Andrew Newland I'd follow his lead

£10 wouldn't be out of the question (c £2bn valuation - mid/upper FTSE250)

a takeover post FDA is the biggest risk of not achieving maximum value. I believe this could become a British global success story which would make its way into every aspect of oncology medicine worldwide, delivering better outcomes for patients and life changing returns for shareholders. Every market segment they could address is worth £billions and so the upside is unparalleled among small listed med tech companies. AN wants his life's work to become a multi billion pound British success story. I have my seat belt on for this ride, hoping that we don't get some silly offer of £2.50 or £3 a share from the US

£100k end of day just under 96p filled

I hope not

X-o is cheap and cheerful...should work for a new starter

KR1 should not follow BTC...there is an indirect link in that BTC tends to trigger confidence in the crypto portfolio held but the KR1 portfolio is in it's infancy and the share price of KR1 should be underpinned by the NAV. But the real melt up upside should be recognition of the quality of the management team for picking early stage investment winners founded on DeFi, and turning them into multi baggers. I still expect that one of KR1's investments will turn into a $billion company...which will be the icing on the cake of the wonderful portfolio of coin winners. This is just starting. I got "Investment Times" from HL today, the UK's biggest retail investor platform (1.5million) and not a word of Bitcoin, cryptocurrency or even the concept of DeFi. Articles about printing money, inflation but not a word about an asset class which addresses this. We are at defcon 1 with DeFi with KR1, early stage evangelists the only ones who really get it. Defcon 2 is where the institutions get in. Defcon 3 is where there is widespread acceptance among commentators. Defcon 4 is when company's start to diversify their balance sheet liquidity to include crypto and Defcon 5 is the retail FOMO investor crowd who look back at years of exponential growth in capital value, wondering why they didn't see the opportunity. Backing KR1 now is like backing Elon Musk in 2004 when his Series A Tesla funding investment was $6.5mn....worth $2.8billion at IPO in 2010, now worth $185bn

https://dailyhodl.com/2021/01/31/top-analyst-reveals-just-how-high-bitcoin-ethereum-and-six-additional-altcoins-can-go-this-cycle/

DOT $350 !

That was succinct! thanks. Final question - RNS last September said that last July's fundraise meant they had enough cash runway to get through to Q1 2021...surely that means the Longevity deal is make or break as without their Balance Sheet cash they will need a huge placing. I like the science here but the £23mn annual losses and brink of running out of cash are offputting. If the SEC say no (or delay) they would be put into a dire position. I want to invest but think I'll hold off until the Longevity deal is unconditional

Am researching this but I can't see what caused the share price to drop from £10 to £2 - was there a high hope value drug trial failure or something in 2017, or a huge share cap dilution. The company look nicely poised now but just don't understand the history of what caused the drop from £10 to where it is today if everything has been progressing on the science side? Appreciate anyone who can share some highlights on this

AGL already do that...FDA approval due Q2

methinks you will get spiked tomorrow....but welcome on board to the UK crypto unicorn in the making!

Argo is too bitcoin focussed for my liking and i do question the environmental credentials of mining via electricity vs staking with alt coins. KR1 really do their homework and look for investment opportunities rather than PR / bitcoin bandwagon. Their focus on defi project applications in the real world could lead to investment returns of 100x-500x which is grounded in better commercials than holding bitcoin on the thesis that it is always going to appreciate in value. KR1 still represent quality at a discount backed up by NAV

But most pre IPO funds have a track record of 7 out of 10 investments being a write off, 1-2 walking wounded and 1-2 moonshots that makes up for the other dreadfuls. KR1's invesment moonshot hit rate is extraordinary, multi-bagging time after time. But they are hardly known and hard to buy so under the mainstream radar for the time being

Now now cryptocurrency just overtaken Ripple market cap. Tomorrow will be interesting (if we weren't trading on Aquis it would be even exciting!)

Agenda is actually 20 years of experience of being an early failed investor in CGNR and having the experience of listening to the chief spoofer one to one....and then realising he talks a good story, plays a heads I win tails you lose game with shareholders money, and has NEVER consummated a JV to date which didn't end in tears or him ousted. Past performance is no guarantee of future performance, but it's a damn good indicator of probable outcomes. It is probable now that this will end in tears for investors. I wish that was not the case. I have no position here in either direction.

Massive over-reaction? It hasn't even started

AAZ can wait. CGNR need this to happen. AAZ have their pick of licences/projects/opportunities. CGNR are in last chance saloon. The complications you point out (jurisdictional) are known and obvious to anyone BEFORE the deal terms were announced so it's nothing to do with that, much as you may wish it to be.

This is a tiny stock so there is no deramping agenda - there is no scope to make money shorting this tiddler.

On balance I believe that the deal WILL NOT happen

AAZ don't have to put out a negative message. It's diplomatic speak for the "wheels have come off the cart unless Prof Con becomes reasonable about the issues we have found"

AAZ share price hardly budget on this RNS

CGNR dived 20%

The rose tinted glasses say that other deals have been held up due to Covid, Brexit, increased regulatory issues/bureaucracy. Wow - show us one. Covid, Brexit and reg/bureaucracy were all there when the heads were inked. It is something else, unpalatable as that may be

At best the deal will go ahead but on re negotiated commercial terms

At worst it will be called off and CGNR will go under. Prof Conroy has an incredible track record of always being the bridesmaid, and the only time he was the bride (at Arcon) he had a massive fall out with Tony O'Reilly his JV partner.

AAZ can discuss the license area with the Irish Government if the deal falls over but they still like the look of the technical data, and for a lot less risk and commitment than the CGNR JV

Welcome to the world of grown up reality without the rose tinted glasses

This will open massively down tomorrow morning when bigger shareholders get home and read that AAZ RNS